{"transactions":[{"id":700828,"issuer":{"id":6149,"kind":"organization","name":"COMPUGEN LTD"},"owners":[{"id":27823,"kind":"person","name":"ZWEIFACH SANFORD S","position":1,"cik":"0001231269","reported_name":"ZWEIFACH SANFORD S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2026-07-30T20:02:19.000Z","date":"2026-07-29","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":10000,"derivative":{"exercise_price":2.26,"expiration_date":"2036-07-29","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001178913-26-003709","document":"zk2635766.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1119774/000117891326003709/zk2635766.xml","form_type":"4"}},{"id":700827,"issuer":{"id":6149,"kind":"organization","name":"COMPUGEN LTD"},"owners":[{"id":27823,"kind":"person","name":"ZWEIFACH SANFORD S","position":1,"cik":"0001231269","reported_name":"ZWEIFACH SANFORD S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-07-30T20:02:19.000Z","date":"2026-07-29","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. The RSUs vest 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":20180,"source":{"system":"sec-edgar","filing":"0001178913-26-003709","document":"zk2635766.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1119774/000117891326003709/zk2635766.xml","form_type":"4"}},{"id":1468100,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":27823,"kind":"person","name":"ZWEIFACH SANFORD S","position":1,"cik":"0001231269","reported_name":"ZWEIFACH SANFORD S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-27T16:56:07.000Z","date":"2024-06-26","kind":"grant","planned":false,"acquired":true,"shares":19350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest with respect to all of the shares underlying such option on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to the non-employee director's continued service as a director."}],"balance_after":19350,"derivative":{"exercise_price":1.22,"expiration_date":"2034-06-26","underlying":"Common Stock","underlying_shares":19350},"source":{"system":"sec-edgar","filing":"0001104659-24-075721","document":"tm2418415-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000110465924075721/tm2418415-4_4seq1.xml","form_type":"4"}},{"id":1558411,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":27823,"kind":"person","name":"ZWEIFACH SANFORD S","position":1,"cik":"0001231269","reported_name":"ZWEIFACH SANFORD S","relationship":{"director":true}}],"security":"Options","published_at":"2024-03-28T12:41:34.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":9.04,"exercise_date":"2025-03-25","expiration_date":"2034-03-25","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950172-24-000141","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000095017224000141/form4.xml","form_type":"4"}},{"id":1862193,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":27823,"kind":"person","name":"ZWEIFACH SANFORD S","position":1,"cik":"0001231269","reported_name":"ZWEIFACH SANFORD S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T18:19:11.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":38700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest over three years in equal monthly installments following June 6, 2023, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date."}],"balance_after":38700,"derivative":{"exercise_price":7.25,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":38700},"source":{"system":"sec-edgar","filing":"0001104659-23-069502","document":"tm2318219-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000110465923069502/tm2318219-6_4seq1.xml","form_type":"4"}},{"id":1960922,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":27823,"kind":"person","name":"ZWEIFACH SANFORD S","position":1,"cik":"0001231269","reported_name":"ZWEIFACH SANFORD S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-09T21:23:35.000Z","date":"2023-03-07","kind":"grant","acquired":true,"shares":184621,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the merger of Sesen Bio, Inc. (\"Sesen Bio\") and private company CARISMA Therapeutics Inc. (\"Carisma\"), pursuant to the Agreement and Plan of Merger and Reorganization dated as of September 20, 2022, as amended by the First Amendment thereto dated as of December 29, 2022 and the Second Amendment thereto dated as of February 13, 2023 (as amended, the \"Merger Agreement\"), which closed on March 7, 2023 (the \"Closing\"), (i) each share of Carisma common stock was converted into the right to receive 1.8994 shares of Sesen Bio common stock (the \"Exchange Ratio\") and (ii) each outstanding and unexercised option to purchase shares of Carisma common stock converted into an option to purchase shares of Sesen Bio common stock, with necessary adjustments to reflect the Exchange Ratio but otherwise the same terms and conditions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Exchange Ratio gives effect to the 1-for-20 reverse stock split of Sesen Bio's common stock. On the Closing date, the closing price of Sesen Bio common stock was $0.6288 (unadjusted). Upon Closing, Sesen Bio was renamed \"Carisma Therapeutics Inc.\""},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest over four years, with 25% of the shares vested on November 9, 2022 and the remaining shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service."}],"balance_after":184621,"derivative":{"exercise_price":1.46,"expiration_date":"2031-11-08","underlying":"Common Stock","underlying_shares":184621},"source":{"system":"sec-edgar","filing":"0001104659-23-030747","document":"tm238905-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000110465923030747/tm238905-6_4seq1.xml","form_type":"4"}},{"id":1960921,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":27823,"kind":"person","name":"ZWEIFACH SANFORD S","position":1,"cik":"0001231269","reported_name":"ZWEIFACH SANFORD S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-03-09T21:23:35.000Z","date":"2023-03-07","kind":"grant","acquired":true,"shares":413,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the merger of Sesen Bio, Inc. (\"Sesen Bio\") and private company CARISMA Therapeutics Inc. (\"Carisma\"), pursuant to the Agreement and Plan of Merger and Reorganization dated as of September 20, 2022, as amended by the First Amendment thereto dated as of December 29, 2022 and the Second Amendment thereto dated as of February 13, 2023 (as amended, the \"Merger Agreement\"), which closed on March 7, 2023 (the \"Closing\"), (i) each share of Carisma common stock was converted into the right to receive 1.8994 shares of Sesen Bio common stock (the \"Exchange Ratio\") and (ii) each outstanding and unexercised option to purchase shares of Carisma common stock converted into an option to purchase shares of Sesen Bio common stock, with necessary adjustments to reflect the Exchange Ratio but otherwise the same terms and conditions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Exchange Ratio gives effect to the 1-for-20 reverse stock split of Sesen Bio's common stock. On the Closing date, the closing price of Sesen Bio common stock was $0.6288 (unadjusted). Upon Closing, Sesen Bio was renamed \"Carisma Therapeutics Inc.\""}],"balance_after":413,"source":{"system":"sec-edgar","filing":"0001104659-23-030747","document":"tm238905-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000110465923030747/tm238905-6_4seq1.xml","form_type":"4"}},{"id":2128449,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":27823,"kind":"person","name":"ZWEIFACH SANFORD S","position":1,"cik":"0001231269","reported_name":"ZWEIFACH SANFORD S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-01T11:10:23.000Z","date":"2022-06-29","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the options vest after 12 months from the date of grant."}],"balance_after":22500,"derivative":{"exercise_price":3.6,"expiration_date":"2032-06-29","underlying":"Common Shares","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001209191-22-054977","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000120919122054977/doc4.xml","form_type":"4"}},{"id":2895173,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":27823,"kind":"person","name":"ZWEIFACH SANFORD S","position":1,"cik":"0001231269","reported_name":"ZWEIFACH SANFORD S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-26T19:03:46.000Z","date":"2020-12-11","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting terms have been amended such that 100% of the options vest after 12 months from the date of grant."}],"balance_after":16500,"derivative":{"exercise_price":7,"expiration_date":"2030-12-11","underlying":"Common Shares","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-21-005516","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000120919121005516/doc4a.xml","form_type":"4/A","original_submission_date":"2021-01-11"}},{"id":2910994,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":27823,"kind":"person","name":"ZWEIFACH SANFORD S","position":1,"cik":"0001231269","reported_name":"ZWEIFACH SANFORD S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-11T16:47:44.000Z","date":"2020-12-11","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options vest after 12 months from the date of grant, and the remaining 75% vest in 36 equal installments with the first installment vesting at the end of the 13th month and subsequent installments vesting on every one month anniversary thereafter."}],"balance_after":16500,"derivative":{"exercise_price":7,"expiration_date":"2030-12-11","underlying":"Common Shares","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-21-002957","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000120919121002957/doc4.xml","form_type":"4"}}]}